Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population.

[1]  V. Mohan,et al.  Absence of Association of Metabolic Syndrome with PPARGC1A, PPARG and UCP1 Gene Polymorphisms in Asian Indians. , 2007, Metabolic syndrome and related disorders.

[2]  V. Mohan,et al.  Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. , 2006, Diabetes care.

[3]  V. Mohan,et al.  Role of Genetic Polymorphism Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala on Ethnic Susceptibility to Diabetes in South-Asian and Caucasian Subjects , 2006, Diabetes Care.

[4]  S. O’Rahilly,et al.  PPARγ and human metabolic disease , 2006 .

[5]  M. Hirata,et al.  Effect of the peroxisome proliferator-activated receptor-γ C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus , 2005, Journal of endocrinological investigation.

[6]  V. Mohan,et al.  Why are Indians more prone to diabetes? , 2004, The Journal of the Association of Physicians of India.

[7]  A. Doney,et al.  Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes , 2004, Diabetologia.

[8]  V. Mohan,et al.  The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). , 2003, The Journal of the Association of Physicians of India.

[9]  V. Mohan,et al.  The genetics of diabetes mellitus. , 2003, The Indian journal of medical research.

[10]  S. Joshi.  Metabolic syndrome--emerging clusters of the Indian phenotype. , 2003, The Journal of the Association of Physicians of India.

[11]  A. Morris,et al.  Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight , 2002, BMC Genetics.

[12]  S. Mudaliar,et al.  PPAR agonists in health and disease: a pathophysiologic and clinical overview , 2002 .

[13]  M. Daly,et al.  Guilt by association , 2000, Nature Genetics.

[14]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.

[15]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[16]  J. Auwerx.  PPARγ, the ultimate thrifty gene , 1999, Diabetologia.

[17]  S. Grundy,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men* , 2022 .

[18]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[19]  A. Pfeiffer,et al.  Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. , 1998, The New England journal of medicine.

[20]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[21]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[22]  J. Auwerx,et al.  A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. , 1998, Human molecular genetics.

[23]  K. Silver,et al.  Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation , 1997 .

[24]  S. Haffner,et al.  Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. , 1997, Diabetes research and clinical practice.

[25]  M. D. Leibowitz,et al.  Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. , 1996, Endocrinology.

[26]  M. Marmot,et al.  Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans , 1992, Diabetologia.

[27]  P. McKeigue.  Coronary heart disease in Indians, Pakistanis, and Bangladeshis: aetiology and possibilities for prevention. , 1992, British heart journal.

[28]  J. Pickup,et al.  Textbook of Diabetes , 1991 .

[29]  H. King,et al.  Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. , 1983, American journal of epidemiology.

[30]  Allan Vaag,et al.  Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? , 2003, Diabetes.

[31]  N. Abate,et al.  The impact of ethnicity on type 2 diabetes. , 2003, Journal of diabetes and its complications.

[32]  M. Marmot,et al.  Coronary heart disease in south Asians overseas: a review. , 1989, Journal of clinical epidemiology.